Therapeutic efficacy of transcatheter hepatic arterial chemoembolization combined with stereotaxis conformal therapy in patients with primary hepatic carcinoma
-
摘要: 目的 观察肝动脉栓塞化疗联合立体定向适形放疗对原发性肝癌患者的疗效.方法 收集本院收治的未接受手术治疗的原发性肝癌患者66例,按治疗方式分为肝动脉栓塞化疗联合立体定向适形放疗的观察组43例,和单纯接受肝动脉栓塞化疗的对照组23例.观察两组患者的近期疗效、远期疗效,治疗前后甲胎蛋白(AFP)的变化及不良反应的发生等.结果 观察组患者的近期治疗有效率为72.1％,显著优于对照组(43.5％)；观察组患者总生存时间和一年生存率均显著优于对照组；2组患者治疗前AFP值无显著差异,治疗后观察组患者AFP显著低于对照组；2组不良反应的发生无统计学差异.结论 肝动脉栓塞化疗联合立体定向适形放疗可显著提高患者的治疗效果.
-
-
Zhang Y, Wang S, Li D. A systems biology-based classifier for hepatocellular carcinoma diagnosis [J]. PLoS One, 2011(7):e22426. 孙燕. 内科肿瘤学 [M]. 北京:人民卫生出版社, 2011.994. Choi J W, Park J Y, Ahn S H. Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection [J]. American Journal of Clinical Oncology, 2009(6):564. Xu L T, Zhou Z H, Lin J H. Clinical study of transarterial chemoembolization combined with 3-dimensional conformal radiotherapy for hepatocellular carcinoma [J]. European Journal of Surgical Oncology, 2011(3):245. 叶胜龙. 原发性肝癌规范化诊治专家共识解读 [A]. 中华医学会第十四次全国病毒性肝炎及肝病学术会议, 2009.62. Kang M K, Kim M S, Kim S K. High-dose radiotherapy with intensity-modulated radiation therapy for advanced hepatocellular carcinoma [J]. Tumori, 2011(6):724. 吴孟超. 原发性肝癌外科综合治疗的现状和展望 [J]. 中华外科杂志, 2004(1):13.doi: 10.3760/j:issn:0529-5815.2004.01.007. Kubota K, Yamanishi T, Itoh S. Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma [J]. Oncology Reports, 2010(3):727. Merle P, Momex F, Trepo C. Innovative therapy for hepatocellular carcinoma:three-dimensional high-dose photon radiotherapy [J]. Cancer Letters, 2009(1):129.
计量
- 文章访问数: 258
- HTML全文浏览量: 31
- PDF下载量: 8
下载:
苏公网安备 32100302010246号